Daniel Von Hoff
≈ 1 min read
Names in other languages
- caDaniel Von Hoff
- DeutschDaniel Von Hoff
- EnglishDaniel Von Hoff
- EspañolDaniel Von Hoff
- FrançaisDaniel Von Hoff
- ItalianoDaniel Von Hoff
- NederlandsDaniel Von Hoff
- slDaniel Von Hoff
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen), and current Virginia G. Piper Distinguished Chair for Innovative Cancer Research at HonorHealth Clinical Research Institute. He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development.
Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen), and current Virginia G. Piper Distinguished Chair for Innovative Cancer Research at HonorHealth Clinical Research Institute. He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1362362154 under CC BY-SA 4.0; modifications have been made.